{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:04:00Z","timestamp":1777860240755,"version":"3.51.4"},"reference-count":46,"publisher":"SAGE Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JRS"],"published-print":{"date-parts":[[2017,5,31]]},"DOI":"10.3233\/jrs-170735","type":"journal-article","created":{"date-parts":[[2017,6,2]],"date-time":"2017-06-02T15:37:16Z","timestamp":1496417836000},"page":"189-196","source":"Crossref","is-referenced-by-count":2,"title":["Common analgesic agents and their role in\u00a0analgesic nephropathy: A commentary of\u00a0the evidence"],"prefix":"10.1177","volume":"28","author":[{"given":"Julian","family":"Yaxley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"issue":"7","key":"10.3233\/JRS-170735_ref1","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1056\/NEJM199802123380707","article-title":"Analgesic nephropathy","volume":"338","author":"De Broe","year":"1998","journal-title":"N Engl J Med"},{"issue":"3","key":"10.3233\/JRS-170735_ref2","doi-asserted-by":"crossref","first-page":"768","DOI":"10.2215\/CJN.04901107","article-title":"Analgesic nephropathy and renal replacement therapy in Australia: Trends, comorbidities and outcomes","volume":"3","author":"Chang","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.3233\/JRS-170735_ref3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00005792-198609000-00002","article-title":"Renal disease from habitual antipyretic analgesic consumption: An assessment of the epidemiologic evidence","volume":"11","author":"Buckalew","year":"1986","journal-title":"Medicine"},{"key":"10.3233\/JRS-170735_ref4","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1681\/ASN.2008101097","article-title":"Over the counter analgesic use","volume":"20","author":"De Broe","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.3233\/JRS-170735_ref5","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/ndt\/gfh040","article-title":"Analgesic nephropathy in Hungary: The HANS study","volume":"19","author":"Pinter","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"19","key":"10.3233\/JRS-170735_ref6","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1056\/NEJM198905113201908","article-title":"Analgesic nephropathy: A preventable renal disease","volume":"320","author":"Bennett","year":"1989","journal-title":"N Engl J Med"},{"issue":"2","key":"10.3233\/JRS-170735_ref7","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/00005792-199803000-00003","article-title":"A review of epidemiologic studies of non-narcotic analgesics and chronic renal disease","volume":"77","author":"Delzell","year":"1998","journal-title":"Medicine"},{"issue":"3","key":"10.3233\/JRS-170735_ref8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1056\/NEJM199101173240304","article-title":"An epidemiologic study of abuse of analgesic drugs: Effects of phenacetin and salicylate on mortality and cardiovascular morbidity (1968 to 1987)","volume":"324","author":"Dubach","year":"1991","journal-title":"N Engl J Med"},{"key":"10.3233\/JRS-170735_ref9","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1093\/ndt\/gfl390","article-title":"Obituary to analgesic nephropathy: An autopsy study","volume":"21","author":"Mihatsch","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.3233\/JRS-170735_ref10","first-page":"167","article-title":"Impact of legislative measures on the sales of analgesics and the subsequent prevalence of analgesic nephropathy: A comparative study in France, Sweden and Belgium","volume":"10","author":"Noels","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.3233\/JRS-170735_ref11","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/ndt\/9.10.1371","article-title":"End-stage renal failure due to analgesic nephropathy, its changing pattern and cardiovascular mortality","volume":"9","author":"Brunner","year":"1994","journal-title":"Nephrol Dial Transplant"},{"key":"10.3233\/JRS-170735_ref12","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/ki.1978.8","article-title":"Analgesic nephropathy in Canada: Clinical syndrome, management and outcome","volume":"13","author":"Gault","year":"1978","journal-title":"Kidney Int"},{"issue":"7","key":"10.3233\/JRS-170735_ref13","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.0954-6820.1979.tb06111.x","article-title":"Mortality from chronic interstitial nephritis and phenacetin consumption in Denmark","volume":"205","author":"Mabeck","year":"1979","journal-title":"Acta Med Scand"},{"issue":"Suppl 42","key":"10.3233\/JRS-170735_ref14","first-page":"86","article-title":"Analgesic nephropathy in the 1990s: An Australian perspective","volume":"44","author":"Nanra","year":"1993","journal-title":"Kidney Int"},{"key":"10.3233\/JRS-170735_ref15","first-page":"500","article-title":"Declining incidence of analgesic nephropathy in Canada","volume":"127","author":"Wilson","year":"1982","journal-title":"Can Med Ass J"},{"key":"10.3233\/JRS-170735_ref16","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1681\/ASN.V123550","article-title":"Trends of analgesic nephropathy in two high-endemic regions with different legislation","volume":"12","author":"Michielsen","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.3233\/JRS-170735_ref17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ki.1978.1","article-title":"Analgesic nephropathy","volume":"13","author":"Kincaid-Smith","year":"1978","journal-title":"Kidney Int"},{"issue":"7","key":"10.3233\/JRS-170735_ref18","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJM198302173080703","article-title":"Epidemiologic study of abuse of analgesics containing phenacetin: Renal morbidity and mortality (1968-1979)","volume":"308","author":"Dubach","year":"1983","journal-title":"N Engl J Med"},{"key":"10.3233\/JRS-170735_ref19","first-page":"35","article-title":"The effect of withdrawal of phenacetin-containing analgesics on the incidence of kidney and urothelial cancer and renal failure","volume":"31","author":"McCredie","year":"1989","journal-title":"Clin Nephrol"},{"issue":"1","key":"10.3233\/JRS-170735_ref20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2165\/00003495-198223010-00004","article-title":"Analgesic nephropathy: A reassessment of the role of phenacetin and other analgesics","volume":"23","author":"Prescott","year":"1982","journal-title":"Drugs"},{"key":"10.3233\/JRS-170735_ref21","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1445-5994.1976.tb03045.x","article-title":"Analgesic abuse and kidney disease","volume":"6","author":"Stewart","year":"1976","journal-title":"Aust NZ J Med"},{"issue":"6","key":"10.3233\/JRS-170735_ref22","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00000441-198806000-00012","article-title":"Southwestern internal medicine conference: Analgesic nephropathy","volume":"295","author":"Henrich","year":"1988","journal-title":"Am J Med Sci"},{"key":"10.3233\/JRS-170735_ref23","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1001\/archinte.164.14.1519","article-title":"Lifetime non-narcotic analgesic use and decline in renal function in women","volume":"164","author":"Curhan","year":"2004","journal-title":"Arch Intern Med"},{"issue":"19","key":"10.3233\/JRS-170735_ref24","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1056\/NEJM198905113201903","article-title":"Analgesic use and chronic renal disease","volume":"320","author":"Sandler","year":"1989","journal-title":"N\u00a0Engl J Med"},{"issue":"25","key":"10.3233\/JRS-170735_ref25","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJM199412223312502","article-title":"Risk of kidney failure associated with the use of acetaminophen, aspirin, and non-steroidal anti-inflammatory drugs","volume":"331","author":"Perneger","year":"1994","journal-title":"N Engl J Med"},{"issue":"2","key":"10.3233\/JRS-170735_ref26","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2105\/AJPH.80.2.153","article-title":"Occupational and other exposures associated with male end-stage renal disease: A case control study","volume":"80","author":"Steenland","year":"1990","journal-title":"Am J Public Health"},{"issue":"3","key":"10.3233\/JRS-170735_ref27","doi-asserted-by":"crossref","first-page":"234","DOI":"10.18553\/jmcp.2012.18.3.234","article-title":"Acute and chronic acetaminophen use and renal disease: A case control study using pharmacy and medical claims","volume":"18","author":"Kelkar","year":"2012","journal-title":"J Manag Care Pharm"},{"issue":"4","key":"10.3233\/JRS-170735_ref28","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1053\/j.ajkd.2007.12.014","article-title":"Association of analgesic use with prevalence of albuminuria and reduced GFR in US adults","volume":"51","author":"Agodoa","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"26","key":"10.3233\/JRS-170735_ref29","doi-asserted-by":"crossref","first-page":"950","DOI":"10.5694\/j.1326-5377.1977.tb131274.x","article-title":"Aspirin, phenacetin, and the kidney: A rheumatism clinic study","volume":"1","author":"Ferguson","year":"1977","journal-title":"Med J Aust"},{"key":"10.3233\/JRS-170735_ref30","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1136\/bmj.1.5908.593","article-title":"Aspirin and the kidney: New Zealand Rheumatism Association Study","volume":"1","author":"Caughey","year":"1974","journal-title":"BMJ"},{"key":"10.3233\/JRS-170735_ref31","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1001\/jama.286.3.315","article-title":"Analgesic use and renal function in men","volume":"286","author":"Rexrode","year":"2001","journal-title":"JAMA"},{"key":"10.3233\/JRS-170735_ref32","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1111\/j.1523-1755.2005.00346.x","article-title":"Case control study of regular analgesic and non-steroidal anti-inflammatory use and end-stage renal disease","volume":"67","author":"Ibanez","year":"2005","journal-title":"Kidney Int"},{"key":"10.3233\/JRS-170735_ref33","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1136\/bmj.1.5908.597","article-title":"Aspirin and analgesic nephropathy","volume":"1","author":"Macklon","year":"1974","journal-title":"BMJ"},{"issue":"1","key":"10.3233\/JRS-170735_ref34","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/jama.1982.03320260039027","article-title":"Aspirin and analgesic nephropathy","volume":"247","author":"Emkey","year":"1982","journal-title":"JAMA"},{"key":"10.3233\/JRS-170735_ref35","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1038\/ki.1995.491","article-title":"A long-term prospective controlled study of analgesic abuse in Belgium","volume":"48","author":"Elseviers","year":"1995","journal-title":"Kidney Int"},{"issue":"25","key":"10.3233\/JRS-170735_ref36","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa010323","article-title":"Acetaminophen, aspirin, and chronic renal failure","volume":"345","author":"Fored","year":"2001","journal-title":"N Engl J Med"},{"issue":"4","key":"10.3233\/JRS-170735_ref37","doi-asserted-by":"crossref","first-page":"E0122899","DOI":"10.1371\/journal.pone.0122899","article-title":"Association of individual non-steroidal anti-inflammatory drugs and chronic kidney disease: A population-based case control study","volume":"10","author":"Ingrasciotta","year":"2015","journal-title":"PLoS One"},{"issue":"15","key":"10.3233\/JRS-170735_ref38","first-page":"1","article-title":"Analgesic use and ESRD in younger age: A case controls study","volume":"8","author":"Van Der Woude","year":"2007","journal-title":"BMC Nephrology"},{"key":"10.3233\/JRS-170735_ref39","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1093\/ndt\/gfn643","article-title":"Non-phenacetin analgesics and analgesic nephropathy: Clinical assessment of high users from a case control study","volume":"24","author":"Michielsen","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.3233\/JRS-170735_ref40","doi-asserted-by":"crossref","first-page":"165","DOI":"10.7326\/0003-4819-115-3-165","article-title":"Non-steroidal anti-inflammatory drugs and the risk for chronic renal disease","volume":"115","author":"Sandler","year":"1991","journal-title":"Ann Int Med"},{"issue":"3","key":"10.3233\/JRS-170735_ref41","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.amjmed.2006.02.015","article-title":"NSAID use and progression of chronic kidney disease","volume":"120","author":"Gooch","year":"2007","journal-title":"Am J Med"},{"key":"10.3233\/JRS-170735_ref42","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/fampra\/cms086","article-title":"Non-steroidal anti-inflammatory drugs and chronic kidney disease progression: A systematic review","volume":"30","author":"Nderitu","year":"2013","journal-title":"Family Practice"},{"key":"10.3233\/JRS-170735_ref43","unstructured":"Josephy D , Mannervik B Molecular Toxicology. 2nd ed. Oxford: Oxford University Press; 2006. p. 514."},{"issue":"4","key":"10.3233\/JRS-170735_ref44","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1093\/ije\/15.4.454","article-title":"Analgesics and kidney disease","volume":"15","author":"Lanes","year":"1986","journal-title":"Int J Epidemiol"},{"issue":"1","key":"10.3233\/JRS-170735_ref45","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0272-6386(96)90046-3","article-title":"Analgesics and the kidney: Summary and recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the National Kidney Foundation","volume":"27","author":"Henrich","year":"1996","journal-title":"Am J Kid Dis"},{"key":"10.3233\/JRS-170735_ref46","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1046\/j.1523-1755.2000.00410.x","article-title":"Relationship between nonphenacetin combined analgesics and nephropathy: A review","volume":"58","author":"Feinstein","year":"2000","journal-title":"Kidney Int"}],"container-title":["International Journal of Risk & Safety in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JRS-170735","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:44:49Z","timestamp":1777509889000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JRS-170735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,31]]},"references-count":46,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3233\/jrs-170735","relation":{},"ISSN":["0924-6479","1878-6847"],"issn-type":[{"value":"0924-6479","type":"print"},{"value":"1878-6847","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,31]]}}}